Here are the DEF 14A proxy statements from Kewaunee Scientific Corp (KEQU) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow KEQU and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KEQU filings page.
Kewaunee Scientific Corporation will hold its 2026 Annual Meeting virtually on August 26, 2026 at 11:00 a.m. Eastern Time. Stockholders will vote on electing three Class I directors to serve until the 2029 meeting, ratifying Forvis Mazars, LLP as independent auditor for fiscal 2027, and approving on an advisory basis the compensation of named executive officers.
The Board is majority independent, with separate Chair and CEO roles and active Audit, Compensation, Financial/Planning, and Nominating and Corporate Governance Committees. Non-employee directors received a $120,000 annual retainer in fiscal 2026, generally half in cash and half in fully vested stock, plus additional cash fees for committee and Board leadership roles.
Executive pay combines base salary, annual incentives tied mainly to EBITDA and non-financial objectives, and long-term incentives in time- and performance-based RSUs under the 2023 Omnibus Incentive Plan. For fiscal 2026, CEO Thomas D. Hull III had base salary of $526,190 and total compensation of $1,965,495, including a $394,967 cash bonus. The company reports net income of $9.618 million in 2026 and a Company Total Shareholder Return value of $227.75 on an initial $100 investment over the three-year measurement period.